Bibliography
Export 53 results:
Filters: Keyword is Recurrence [Clear All Filters]
Recurrence of chronic active Epstein-Barr virus infection from donor cells after achieving complete response through allogeneic bone marrow transplantation. Internal medicine (Tokyo, Japan)// // Intern Med. 2012;51(7):777-82.
Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology. 2010;117(5):890-6.
Transmission of donor melanoma by organ transplantation. Lancet Oncol. 2010;11(8):790-6.
Candida glabrata endophthalmitis following penetrating keratoplasty. J Cataract Refract Surg. 2009;35(3):598-602.
Chagas' disease reactivation with skin symptoms in a patient with kidney transplant. Int J Dermatol. 2007;46(6):607-10.
Early recurrence of neurocysticercosis after orthotopic liver transplant. Liver Transpl. 2006;12(3):490-1.
Liver transplantation for hepatitis C. J Hepatobiliary Pancreat Surg. 2006;13(5):382-92.
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc. 2005;37(2):817-8.
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma. 2005;46(11):1671-4.
Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):962-3.
New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol. 2004;137(3):415-9.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion. 2003;43(8):1153-61.
Cutaneous manifestation of reactivation of Chagas disease in a renal transplant patient: long-term follow-up. Arch Dermatol. 2003;139(1):104-5.
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol. 2003;72(3):220-2.
De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Donor-to-host transmission of Candida albicans after corneal transplantation. Am J Ophthalmol. 2002;134(1):120-1.
Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol. 2002;119(3):777-80.
Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience. Transplant Proc. 2001;33(40762):3656-7.
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haematol. 2001;113(4):1072-5.
Recurrent transfusion-related acute lung injury. Transfusion//Transfusion. 2001;41(11):1421-5.
Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica. 2000;85(11):1153-7.